Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)

DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01402830

Enrollment

271

Registered

2011-07-26

Start date

2007-11-30

Completion date

2008-03-31

Last updated

2013-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Pain

Keywords

cancer, depression, pain

Brief summary

The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.

Detailed description

This is a retrospective observational and case-control multicenter study. The main objective of this study is determine the degree of association between cancer pain and depression by impact assessment of adequate control of pain associated with cancer risk depression in patients attending the Oncology Unit. The assessment of pain intensity will be performed by using visual analogue scales (EVAs) and verbal descriptive scales, as an observational study, not limit or modify the use of any drug. The patients included in this study have a medical history of cancer pain and mild depression (Beck = 8). The controls are patients with history of cancer pain and mild or absent depression (Beck = 7). n/a

Interventions

OTHERVisual analogue scales (EVAs)

This scale measures the pain intensity.

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients =18 years old * have medical data of = 3 months * experience pain after cancer diagnosis and complete the Beck Depression Inventory (BDI) * patients who give informed written consent * patients with no mental or physical disorders that unable them to complete the BDI.

Exclusion criteria

* Patients with diagnosis of depression before cancer diagnosis * patients with chronic pain prior to the diagnosis of cancer, and cancer disease has not changed its course * patients with other previous mental disorders * patients who do not give their informed written consent.

Design outcomes

Primary

Measure	Time frame
Beck Depression Inventory	3 months
Visual scales analog (EVAs)	3 months

Secondary

Measure	Time frame
Number of patients with cancer pain.	3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026